DAPK1 and neoplasm: Yuan et al. [15] reported that downregulation of DAPK1 promotes chemoresistance and metastasis of colorectal cancer, while inhibition of DAPK1 promotes the epithelial-to-mesenchymal transition (EMT) of tumor stem cells.